RESUMO
<p><b>OBJECTIVE</b>To identify specific protein markers for renal cell carcinoma detection and diagnosis, as well as develop new potential therapeutic targets of the disease.</p><p><b>METHODS</b>We used two-dimensional difference in-gel electrophoresis (2-D DIGE) technique conjunction with mass spectrometry (MS) for the identification of significant differentially expressed proteins between 15cases of paired clear cell renal cell carcinoma (ccRCC) and adjacent normal renal tissues. The protein spots were considered as differentially expressed if a 1.5-fold altered expression level was observed (Student's t test, P value<0.05).</p><p><b>RESULTS</b>Of the 27 differentially expressed protein spots, 26 proteins were successfully identified. 11 proteins up-regulated in renal cell carcinoma,15 proteins down-regulated. Among them Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial (ACDSB), Aldose 1-epimerase (GALM), Peroxiredoxin-4 (PRDX4), Macrophage-capping protein (CAPG), Beta-defensin 107 (D107A), Microfibril-associated glycoprotein 4 (MFAP4) were first time screening as new differential expressed proteins by protomic study in renal cell carcinoma.</p><p><b>CONCLUSIONS</b>2-D DIGE is a useful technique for screening and analysis differential expressed proteins in renal cell carcinoma. These new differently expressed proteins may be useful for development new molecular markers for the tumor.</p>
RESUMO
<p><b>OBJECTIVE</b>To compare the therapeutic effect of 3 minimally invasive approaches for ureteral calculi removal and analyze their respective advantages and limitations.</p><p><b>METHODS</b>A retrospective analysis was conducted in 326 patients receiving extracorporeal shock wave lithotripsy (ESWL), ureteroscopic lithotripsy (URL) or percutaneous nephrolithotripsy (PCNL) for ureteral calculi. The clinical data including the stone-free rate and complications were analyzed.</p><p><b>RESULTS</b>The stone free rate was 78.5% (146/186), 91.2 (93/102) and 100% (38/38) in the 3 groups, respectively. According to the stone size, the ESWL group were divided into 3 groups with stone sizes of 0.5-1.0 cm, 1.0-2.0 cm and beyond 2.0 cm, and the stone-free rates were 90.8% (89/98), 69.3% (52/75), and 30.8% (5/13), respectively, showing significant difference between them (P<0.01). In URL group, surgical failure occurred in 9 cases, including 3 cases with difficult entry of the ureter, 5 with stone displacement to the kidneys, and 1 with residual stones over 4 mm. In PCNL group, the percutaneous renal access was successfully established and immediate phase I lithotripsy was performed in all the patients without severe complications recorded during nephrolithotripsy.</p><p><b>CONCLUSION</b>ESWL is the best option for cases with stone smaller than 10 mm. URL suits most of ureteral calculus cases, but successful entrance of the ureteroscope is a prerequisite and retrograde stone displacement is the primary reason for surgical failure. PCNL is effective in the management of complex upper ureteral stones, especially in cases of failed ESWL or ureteroscopy.</p>